Concepedia

Antonio Maria Grimaldi

AM

49

Publications

3.1K

Citations

26

H-Index

2010

Active since

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituti di Ricovero e Cura a Carattere Scientifico

European Institute of Oncology

Karolinska Institutet

Antonio Maria Grimaldi is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2010–2024

49

Publications

49

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Mariaelena Capone, Diana Giannarelli, Domenico Mallardo et al. · Journal for ImmunoTherapy of Cancer · 2018 · 499 citations · Full text

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

Antonio Maria Grimaldi, Ester Simeone, Diana Giannarelli et al. · OncoImmunology · 2014 · 370 citations · Full text

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Ester Simeone, Giusy Gentilcore, Diana Giannarelli et al. · Cancer Immunology Immunotherapy · 2014 · 250 citations · Full text

, , +12

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci et al. · Journal of Clinical Oncology · 2022 · 208 citations

Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination

Ignacio Melero, Antonio Maria Grimaldi, José Luis Perez‐Gracia et al. · Clinical Cancer Research · 2013 · 170 citations

, , +27

Rows per page

1–5 of 49